Influence of CYP2D6 ,CYP3A4 ,CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers-Reference-Cited by-同舟云学术

Influence of CYP2D6 ,CYP3A4 ,CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

Published:2018-02-22 Issue:6 Volume:122 Page:596-605
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Belmonte Carmen¹²,Ochoa Dolores¹²,Román Manuel¹²,Saiz-Rodríguez Miriam¹,Wojnicz Aneta¹,Gómez-Sánchez Clara Isabel³,Martín-Vílchez Samuel¹,Abad-Santos Francisco¹²⁴

Affiliation:

1. Clinical Pharmacology Department; Hospital Universitario de la Princesa; Instituto Teofilo Hernando; Instituto de Investigacion Sanitaria Princesa (IP); Madrid Spain

2. UICEC Hospital Universitario de la Princesa, Plataforma SCReN (Spanish Clinical Reseach Network); Instituto de Investigacion Sanitaria la Princesa (IP); Madrid Spain

3. Department of Genetics; IIS-Fundacion Jimenez Dıaz University Hospital (IIS-FJD, UAM); Madrid Spain

4. Center for Biomedical Research Network Hepatic and Liver diseases (CIBERedh) - Instituto de Salud Carlos III; Madrid Spain

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12960/fullpdf

Reference52 articles.

1. Food and Drug Administration Aripiprazole label 2014 http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021436s038,021713s030,021729s022,021866s023lbl.pdf

2. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors;Burris;J Pharmacol Exp Ther,2002

3. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor;Jordan;Eur J Pharmacol,2002

4. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology;Shapiro;Neuropsychopharmacology,2003

5. Aripiprazole: profile on efficacy and safety;Goodnick;Expert Opin Pharmacother,2002

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Pharmacogenetics and the Blood–Brain Barrier: A Whirlwind Tour of Potential Clinical Utility;Future Pharmacology;2024-09-05

3. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

4. SLCO1B1 and ABCG2 genotype‐informed phenotypes are related to variation in ramipril exposure;Basic & Clinical Pharmacology & Toxicology;2024-07-16

5. Drug–drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics;Frontiers in Psychiatry;2024-06-18